KATHLEEN KIRCHMEIER KROESSLER
Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology ATTLEBORO, MA NPI 1720005481
Browse related groups: Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology MA ABBVIE INC. All categories
General Payments — all program years on this page
$7,274.36
- Category: General Payments
- Program years: PY2018–2024
- Record count: 306
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $2,218.30 across 69 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $2,218.30 | 69 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $407.65 | 17 |
| Lundbeck LLC | $333.14 | 7 |
| EMD Serono, Inc. | $279.96 | 3 |
| JAZZ PHARMACEUTICALS INC. | $187.35 | 4 |
| UCB, Inc. | $121.81 | 2 |
| Alexion Pharmaceuticals, Inc. | $113.88 | 1 |
| SK Life Science, Inc. | $105.58 | 1 |
| Lilly USA, LLC | $96.54 | 5 |
| Inspire Medical Systems, Inc. | $75.45 | 4 |
| PFIZER INC. | $69.73 | 4 |
| Genentech USA, Inc. | $64.82 | 3 |
| Teva Pharmaceuticals USA, Inc. | $60.94 | 3 |
| Vanda Pharmaceuticals Inc. | $58.00 | 3 |
| TG THERAPEUTICS, INC. | $45.15 | 2 |
| Alnylam Pharmaceuticals Inc. | $37.58 | 1 |
| Neurocrine BioSciences, Inc. | $35.96 | 2 |
| ARGENX US, INC. | $34.42 | 2 |
| CSL Behring | $21.04 | 1 |
| MITSUBISHI TANABE PHARMA AMERICA, INC. | $20.66 | 1 |
| Amgen Inc. | $19.13 | 1 |
| Celgene Corporation | $16.00 | 1 |
| ACADIA Pharmaceuticals Inc | $13.51 | 1 |
By program year
Records — PY2024 (69)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.